Broad spectrum pro-quorum-sensing molecules as inhibitors of virulence in vibrios

US9573908B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9573908-B2
Application numberUS-201314381432-A
CountryUS
Kind codeB2
Filing dateFeb 20, 2013
Priority dateFeb 27, 2012
Publication dateFeb 21, 2017
Grant dateFeb 21, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Using a whole-cell high-throughput screen, eleven molecules were identified that activate V. cholerae quorum sensing (QS). Eight molecules are receptor agonists and three molecules are antagonists of LuxO, the central NtrC-type response regulator that controls the global V. cholerae QS cascade. Pro-QS molecules are used for the development of novel anti-infectives.

First claim

Opening claim text (preview).

The invention claimed is: 1. A compound from the group consisting of: 2. A method for inhibiting virulence of gram negative quorum sensing Vibrio bacteria that employ the quorum sensing response regulator LuxO, the method comprising contacting gram negative quorum sensing Vibrio bacteria that comprise the quorum sensing response regulator LuxO with a compound from a group consisting of in an amount that inhibits the quorum sensing response regulator LuxO. 3. The method of claim 2 wherein the bacteria are Vibrio cholerae or Vibrio parahaemolyticus. 4. A method for prophylactic treatment of a host organism, including but not limited to humans, domesticated or wild mammals, domesticated or wild avian species, domesticated or wild fish, and domesticated or wild mollusks, at risk for an imminent and potentially deleterious infection with a member of the vibrio species of bacteria, to inhibit bacterial pathogenicity of Vibrio bacteria that employ the quorum sensing response regulator LuxO, the method comprising contacting gram negative quorum sensing Vibrio bacteria that comprise the quorum sensing response regulator LuxO with a compound from a group consisting of in an amount that inhibits the quorum sensing response regulator LuxO. 5. A method for inhibiting biofilm formation by gram negative quorum sensing Vibrio bacteria that employ the quorum sensing response regulator LuxO, the method comprising contacting the Vibrio bacteria that comprise the quorum sensing response regulator LuxO with a compound from a group consisting of in an amount that inhibits the quorum sensing response regulator LuxO.

Assignees

Inventors

Classifications

  • 1,2,3- or 1,2,4-triazines; Hydrogenated 1,2,3- or 1,2,4-triazines · CPC title

  • containing nitrogen {having a Si-N linkage} · CPC title

  • Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur (containing organo-phosphorus compounds A01N57/00) · CPC title

  • Two hetero atoms, in positions 3 and 5 · CPC title

  • having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine (melarsoprol A61K31/555 {; with four nitrogen atoms A61K31/495}) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9573908B2 cover?
Using a whole-cell high-throughput screen, eleven molecules were identified that activate V. cholerae quorum sensing (QS). Eight molecules are receptor agonists and three molecules are antagonists of LuxO, the central NtrC-type response regulator that controls the global V. cholerae QS cascade. Pro-QS molecules are used for the development of novel anti-infectives.
Who is the assignee on this patent?
Bassler Bonnie L, Ng Wai-Leung, Perez Lark J, and 3 more
What technology area does this patent fall under?
Primary CPC classification C07D253/075. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).